Related Experiment Video
Updated: Mar 11, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
Enhanced laboratory capacity development: a boost for effective tuberculosis control in resource-limited settings
Abraham Sunday Alabi1, Afsatou Ndama Traoré2, Marguerite Massinga Loembe3
1Centre des Recherches Médicales de Lambaréné (CERMEL), PB 118, Lambaréné, Gabon; Eberhard Karls Universität, Institut für Tropenmedizin, Tübingen, Germany.
Sub-Saharan Africa urgently needs expanded tuberculosis (TB) laboratory capacity. The Centre de Recherches Médicales de Lambaréné (CERMEL) in Gabon successfully built a TB lab, improving diagnosis and treatment, serving as a model for high-prevalence regions.
Area of Science:
- Global Health
- Infectious Disease Research
- Laboratory Capacity Building
Background:
- Sub-Saharan Africa faces significant challenges in tuberculosis (TB) diagnosis and control due to limited laboratory infrastructure.
- Expansion of both routine and research TB laboratory capacity is critical for improving public health outcomes in the region.
Purpose of the Study:
- To describe the strategic development and impact of a tuberculosis laboratory at the Centre de Recherches Médicales de Lambaréné (CERMEL) in Gabon.
- To evaluate CERMEL's contribution to TB diagnosis, treatment, control, and research capacity in Central Africa.
Main Methods:
- Strategic decision in 2009 to expand laboratory activities focusing on TB.
- Development of a standard laboratory over seven years.
- Collaboration with the Gabon National TB Control Programme (PNLT) and joint Global Fund application.
Main Results:
- Established a functional TB laboratory significantly contributing to TB diagnosis, treatment, and control in Gabon.
- Provided essential training for TB research staff across Central Africa.
- Forged a successful partnership with the PNLT, leading to a joint Global Fund application.
Conclusions:
- The CERMEL TB laboratory serves as a successful model for enhancing diagnostic and treatment capacity in high TB prevalence areas.
- This initiative demonstrates a viable approach for similar developments needed in regions with poor TB control.
- Strengthened laboratory infrastructure and collaborative efforts are key to combating tuberculosis effectively.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

